RARE has been in the news 321% more than usual
Feb 24, 2026, 3:32 PM
-3.18%
What does RARE do
Ultragenyx Pharmaceutical, based in Novato, California, focuses on developing therapies for rare genetic diseases and has four approved products, including Crysvita and Mepsevii. The company went public on January 31, 2014, and employs 1,276 people.
RARE has been in the news recently: Ultragenyx Pharmaceutical Inc. is facing a class action lawsuit filed by Schall Law Firm, alleging securities violations related to stock purchases made between August 3, 2023, and December 26, 2025, with a deadline for investors to contact the firm by April 6, 2026. The company's stock experienced a significant decline of 42.32% after its studies did not meet crucial endpoints, leading to the initiation of the class action.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.